A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Background: Reducing glycemic fluctuation is important for optimal diabetes management. This post hoc analysis examined glycemic fluctuations and the proportion of subjects achieving recommended blood glucose targets with the fixed ratio combination of insulin degludec and liraglutide (IDegLira) com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: King, Allen B., Philis-Tsimikas, Athena, Kilpatrick, Eric S., Langbakke, Irene H., Begtrup, Kamilla, Vilsbøll, Tina
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399738/
https://ncbi.nlm.nih.gov/pubmed/28282219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados